|
Post by MnkdWASmyRtrmntPlan on May 23, 2020 10:47:47 GMT -5
Dr. Kendall is in the presentation team at ADA 2020: professional.diabetes.org/sites/professional.diabetes.org/files/media/2020_virtual_scientific_sessions_program_-_5.14.20.pdfSUNDAY, JUNE 14, 2020 5:30 p.m.-5:45 p.m. - 235-OR Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin MARISA C. JONES, TIFFANY S. TRAN, JOHN A. KRUEGER, PATRICK M. MOREY, BYRON J. HOOGWERF, DAVID M. KENDALL, Westlake Village, CA, Sarasota, FL Some insight into the other MNKD presenters at that discussion: - Marisa C. Jones – fresh out of college - pharmacyschool.usc.edu/commencement-spotlight-marisa-jones/- Tiffany S. Tran - now, HERE's an interesting one. Although she is listed in the ADA's sessions listing as being a presenter along with Dr. Kendall, her LinkedIn says she left MNKD last month to take a job with AMGEN!!! Yes, AMGEN - xhttps://www.linkedin.com/in/tiffany-tran-1620b272 - John A. Krueger - VP Pharmaceutical Development - xhttps://www.linkedin.com/in/john-krueger-277b9827/ - Patrick Morey - Strategy & Operations Lead, Clinical Development and Medical Affairs - xhttps://www.linkedin.com/in/patrick-morey-91a97874/ sorry but I had problems with the above Linkedin links. The only way I could get the links to display is by adding a preceding letter x. So, copy the link into your browser except for the letter x and they should work.
|
|
|
Post by goyocafe on May 23, 2020 13:57:48 GMT -5
|
|
|
Post by cretin11 on May 23, 2020 18:17:16 GMT -5
The Amgen-MNKD connection again! What is up with that? Both companies seem to be “feeders” for each other regarding employees. Plus it teases us with dreams of collab/buy-in/buy-out with Amgen. Sometimes where there’s smoke there’s fire, but so far only smoke here.
At this point it’s almost become a joke, or more nicely put, like the boy who cried wolf. We’ve been discussing it for years now. Does anyone still think there’s synergy of any type on the horizon with Amgen?
|
|
|
Post by sportsrancho on May 23, 2020 20:38:38 GMT -5
The Amgen-MNKD connection again! What is up with that? Both companies seem to be “feeders” for each other regarding employees. Plus it teases us with dreams of collab/buy-in/buy-out with Amgen. Sometimes where there’s smoke there’s fire, but so far only smoke here. At this point it’s almost become a joke, or more nicely put, like the boy who cried wolf. We’ve been discussing it for years now. Does anyone still think there’s synergy of any type on the horizon with Amgen? No
|
|
|
Post by letitride on May 23, 2020 22:40:29 GMT -5
Its beginning to feel like musical chairs, cant wait to see whos to short to find a seat when the music stops. PS: I havent a clue, but damn it sure does keep it interesting!
|
|
|
Post by babaoriley on May 24, 2020 0:45:26 GMT -5
Its beginning to feel like musical chairs, cant wait to see whos to short to find a seat when the music stops. PS: I havent a clue, but damn it sure does keep it interesting! Letitride, you must like really, really long novels!! Lol
|
|
|
Post by letitride on May 24, 2020 9:25:04 GMT -5
Thus Letitride Lets Go!
|
|
|
ADA 2020
May 24, 2020 10:33:35 GMT -5
via mobile
Post by sellhighdrinklow on May 24, 2020 10:33:35 GMT -5
Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin.
Are we assuming this to be a positive " significant change"? Seems like this would be a negative change but I definitely hope I'm wrong.
|
|
|
ADA 2020
May 24, 2020 10:45:11 GMT -5
via mobile
Post by sellhighdrinklow on May 24, 2020 10:45:11 GMT -5
I do not see a presentation on Type 2s using Afrezza and CGM and the outcome. Does anybody see it listed? TYIA.
|
|
|
Post by agedhippie on May 24, 2020 11:24:58 GMT -5
Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin. Are we assuming this to be a positive " significant change"? Seems like this would be a negative change but I definitely hope I'm wrong. It's given by Mannkind, it's safe to say it's definitely not going to be negative.
|
|
|
ADA 2020
May 24, 2020 13:30:19 GMT -5
via mobile
Post by longliner on May 24, 2020 13:30:19 GMT -5
Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin. Are we assuming this to be a positive " significant change"? Seems like this would be a negative change but I definitely hope I'm wrong. That was my first thought as well.
|
|
|
Post by Clement on May 24, 2020 16:42:57 GMT -5
Incidence of significant changes = Zero
That would be positive. Doctors need to continue hearing this.
|
|
|
Post by letitride on May 24, 2020 17:36:26 GMT -5
I heard rumor pulmonary function improves with long term use of afrezza, much like every other bodily function when you achieve homeostasis.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 24, 2020 17:38:17 GMT -5
I heard rumor pulmonary function improves with long term use of afrezza, much like every other bodily function when you achieve homeostasis. Thats true.
|
|
|
ADA 2020
May 25, 2020 8:58:38 GMT -5
via mobile
Post by sellhighdrinklow on May 25, 2020 8:58:38 GMT -5
I do not see a presentation on Type 2s using Afrezza and CGM and the outcome. Does anybody see it listed? TYIA. I thought the results of this study were waiting to be presented at ADA 2020. Statements were made regarding this on another thread.
|
|